• AVANTAGES
  • Canadian Investment Review
  • CIIN
  • EVENTS
  • Webinars
  • AWARDS
Benefits Canada.com
  • Newsletter
  • Magazine
  • My account

Top 5 HR, pension and benefits stories of the week

Share
Facebook
LinkedIn
Twitter
Mail to a fried
Print
  • News
  • Benefits
    • Absence management
    • Communication
    • Disability management
    • Health benefits
    • Health/wellness
    • Legal issues
    • Other
  • Pensions
    • Capital accumulation plans
    • Governance/legislation
    • Retirement
    • Communication
    • Other
  • Investments
    • News
    • Partner Content
    • Expert Panel
    • DB
    • DC
    • Public Equities
    • Fixed income
    • Alternative investments
    • Investment Strategies
    • Research & Markets
    • Other
  • HR
    • Communication
    • Legal issues
    • Other
  • Expert Panel
  • Partner content
    • Partner Sites
    • Partner Series
    • Partner Education
    • Directories
  • Top stories in People Watch
  • Resource Library
  • Events
  • Webinars
  • Awards
  • News
  • Benefits
    • Absence management
    • Communication
    • Disability management
    • Health benefits
    • Health/wellness
    • Legal issues
    • Other
  • Pensions
    • Capital accumulation plans
    • Governance/legislation
    • Retirement
    • Communication
    • Other
  • Investments
    • News
    • Partner content
    • Expert Panel
    • DB
    • DC
    • Public Equities
    • Fixed income
    • Alternative investments
    • Investment Strategies
    • Research & Markets
    • Other
  • HR
    • Communication
    • Legal issues
    • Other
  • Partner content
    • Sites
    • Series
    • Research
    • Education
    • Roundtables
    • Directories
  • People Watch
  • Resource Library
Top 5 HR, pension and benefits stories of the week

Top 5 HR, pension and benefits stories of the week

  • By: Staff
  • February 4, 2022 February 4, 2022
  • 09:05
Share
Facebook
LinkedIn
Twitter
Mail to a fried
Print
Staff

A deep dive into how AstraZeneca is helping employees keep socially connected and engaged as year three of the coronavirus pandemic looms took the top spot over the past week on BenefitsCanada.com.

Here are the five most popular news stories of the week:

1. How AstraZeneca is boosting employee connection, engagement amid pandemic

2. Survey finds majority of Gen Z, millennials dealing with anxiety, depression

3. Canadians struggling with financial, mental well-being: surveys

4. Benefits tops list of retention tools for employers: survey

5. How a Montreal tech company is helping staff stay active amid pandemic

Related news

CIA focusing on climate risk, VPLAs in 2026

2025 Future of Work Summit: Rebuilding workplace connections is key in hybrid, remote working arrangements

Webinar coverage: Early diagnosis, high-efficacy treatments transforming life with MS

Keywords
Health/wellness,
 
Human resources,
 
Retirement,
 
Financial wellness,
 
Mental health,
 
The Great Resignation,
 
Employee engagement,
 
Flexible workplace,
 
Coronavirus pandemic
Share this article and your comments with peers on social media
  • Facebook
  • LinkedIn
  • Twitter

Subscribe

Newsletters Magazine Flipbook

Connect

Partner Content

Featured Content

See all

Careers

  • Post a job

Latest news

Webinar coverage: Early diagnosis, high-efficacy treatments transforming life with MS

Canada has the highest rate of multiple sclerosis in the world, with an estimated 90,000 to 100,000 people living with the disease. Every day, 12...

  • By: Suzanne Lepage
  • January 14, 2026 January 13, 2026
  • 08:00

Webinar coverage: New brain tumour treatment offers hope for working Canadians

Glioma, the most common malignant brain tumour in young adults under 50 is a devastating disease that often strikes people in their prime working years,...

  • By: Suzanne Lepage
  • January 14, 2026 January 13, 2026
  • 08:00

Webinar coverage: New treatment marks a turning point in Alzheimer’s care

Health Canada recently approved the first disease-modifying therapy for Alzheimer’s disease, which is a long-awaited milestone that carries significant implications for private drug plans, employers...

  • By: Suzanne Lepage
  • January 14, 2026 January 13, 2026
  • 08:00

WISE Trust Appoints Stacey Parker-Yull as Vice President, Pension Strategy and Services

WISE Trust is pleased to announce the appointment of Stacey Parker-Yull as Vice President, Pension Strategy and Services. Parker-Yull joins WISE Trust at a pivotal...

  • January 12, 2026 January 12, 2026
  • 09:20

Today's top stories

CIA focusing on climate risk, VPLAs in 2026

In 2026, the Canadian Institute of Actuaries will continue to focus on the impact of climate risk on several areas, including pension investments, says Angelita...

  • By: Blake Wolfe
  • January 14, 2026 January 13, 2026
  • 09:00

2025 Future of Work Summit: Rebuilding workplace connections is key in hybrid, remote working arrangements

With many companies mandating returns to onsite offices, a disconnect has been gradually building in how employers are approaching remote and hybrid work versus their...

  • By: Sadie Janes
  • January 14, 2026 January 14, 2026
  • 09:00

ESG considerations leading to higher private equity returns: BCI

The British Columbia Investment Management Corp. is seeing higher returns in the private equity market following the adoption of an environmental, social and governance lens,...

  • By: Bryan McGovern
  • January 13, 2026 January 12, 2026
  • 11:00

Expert panel: Plan sponsors focusing on financial, mental health amid ongoing economic uncertainty

In 2025, many organizations took steps to address an uncertain economy while responding to changing pressures. Looking ahead to 2026, there are some trends and...

  • By: Kim Siddall
  • January 13, 2026 January 12, 2026
  • 09:00
Newsletters
My account
Contact Us
  • BENEFITS CANADA
  • About Us
  • Advisory Boards
  • Contact Us
  • Customer Service
Footer CIR
  • CANADIAN INVESTMENT REVIEW
  • About Us
  • Advisory Board
  • Contact Us
Subscribe
  • SUBSCRIBE
  • Magazine
  • Newsletter
ADVERTISE WITH US
  • ADVERTISE WITH US
  • Benefits Canada Media Kit
  • Canadian Investment Review Media Kit
  • Statement of Ethics
  • Archives
  • Current Issue
  • Acquizition.Biz
  • Avantages
  • Benefits Canada
  • CIIN
  • Canadian Investment Review
  • Statement of Ethics
  • Terms of Use
  • Privacy Policy

© 1998- Contex Group Inc. All rights reserved.

Groupe Context

Contex Group Inc.
355, Sainte-Catherine West, suite 501
Montréal, QC H3B 1A5
(514) 392-2009